Trimethylammonium

Trimethylammonium

SCHEMBL136534

CCC=C(C)C(=O)O.CN(C)C.Cl

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Trimethylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PTGS1 known ✓ P23219 1/20 0.31
GRIK1 P39086 1/20 0.35
GRIK2 Q13002 1/20 0.35
CD81 P60033 1/20 0.32
AKR1C3 P42330 1/20 0.31
EP300 Q09472 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trimethylammonium SCHEMBL11169491 1.00 GRIK1 (0.35) GRIK1GRIK2CD81PTGS1AKR1C3
Trimethylammonium SCHEMBL136535 1.00 GRIK1 (0.35) GRIK1GRIK2CD81PTGS1AKR1C3
Trimethylammonium SCHEMBL1469277 0.98 GRIK1 (0.36) GRIK1GRIK2CD81PTGS1AKR1C3
Trimethylammonium SCHEMBL679439 0.98 GRIK1 (0.36) GRIK1GRIK2CD81PTGS1AKR1C3
Trimethylammonium SCHEMBL27571825 0.95 GRIK1 (0.35) GRIK1GRIK2CD81PTGS1AKR1C3
Hydrochloric Acid SCHEMBL2564983 0.93
SCHEMBL17819 0.90
SCHEMBL17817 0.90
SCHEMBL5716965 0.90
N,N-Dimethylethanaminium SCHEMBL11902174 0.88 GRIK1 (0.34) GRIK1GRIK2CD81PTGS1AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11766638-B2 Ion-exchange membrane having an imprinted non-woven substrate BL TECHNOLOGIES, INC. (US) 2023-09-26 US claimed
US-20210394121-A1 ION-EXCHANGE MEMBRANE HAVING AN IMPRINTED NON-WOVEN SUBSTRATE BL TECHNOLOGIES, INC. 2021-12-23 US claimed
US-11135551-B2 Ion-exchange membrane having an imprinted non-woven substrate BL TECHNOLOGIES, INC. (US) 2021-10-05 US claimed
EP-3600628-A1 ION-EXCHANGE MEMBRANE HAVING AN IMPRINTED NON-WOVEN SUBSTRATE BL Technologies, Inc. (US) 2020-02-05 EP claimed
US-10486151-B2 Ion-exchange membrane with multi-layered support substrate BL TECHNOLOGIES, INC. (US) 2019-11-26 US claimed
WO-2018174848-A1 ION-EXCHANGE MEMBRANE HAVING AN IMPRINTED NON-WOVEN SUBSTRATE GENERAL ELECTRIC COMPANY (US) 2018-09-27 WO claimed
US-20180043345-A1 ION-EXCHANGE MEMBRANE WITH MULTI-LAYERED SUPPORT SUBSTRATE BL TECHNOLOGIES, INC. 2018-02-15 US claimed
EP-1878760-B1 Hybrid polymer materials through copolymerisation FRAUNHOFER GES FORSCHUNG (DE) 2010-03-03 EP claimed
US-11766638-B2 Ion-exchange membrane having an imprinted non-woven substrate BL TECHNOLOGIES, INC. (US) 2023-09-26 US disclosed
CN-115843308-A Biocompatible devices with cationic comb copolymer adsorbent layers 法切利塔特有限公司 2023-03-24 CN disclosed
US-20210394121-A1 ION-EXCHANGE MEMBRANE HAVING AN IMPRINTED NON-WOVEN SUBSTRATE BL TECHNOLOGIES, INC. 2021-12-23 US disclosed
US-11135551-B2 Ion-exchange membrane having an imprinted non-woven substrate BL TECHNOLOGIES, INC. (US) 2021-10-05 US disclosed
CN-112739446-A Monovalent selective cation exchange membranes 懿华水处理技术有限责任公司 2021-04-30 CN disclosed
EP-3600628-A1 ION-EXCHANGE MEMBRANE HAVING AN IMPRINTED NON-WOVEN SUBSTRATE BL Technologies, Inc. (US) 2020-02-05 EP disclosed
US-5981816-A USING HYDROSOLUBLE NEUTRAL OR POSITIVELY CHARGED HOMOPOLYMERS OR COPOLYMERS, OR POLYAMPHOLYTES, WHICH DERIVE FROM ONE OR MORE NITROGEN-CONTAINING MONOMERS, TO INHIBIT OR RETARD HYDRATE FORMATION, GROWTH INSTITUT FRANCAIS DU PETROLE (FR) 1999-11-09 US disclosed
US-5925722-A DECOMPOSING STARCH BY ACID HYDROLYSIS WITH ENZYME; EMULSION ADDITION POLYMERIZATION GIULINI CHEMIE GMBH (DE) 1999-07-20 US disclosed
US-5316772-A Bilayered oral pharmaceutical composition with pH dependent release SOLVAY & CIE, S.A. (SOCIETE ANONYME) (BE) 1994-05-31 US disclosed
WO-1992011001-A1 ORAL PHARMACEUTICAL COMPOSITION SOLVAY (SOCIETE ANONYME) (BE) 1992-07-09 WO disclosed
US-4367297-A Water-soluble poly(meth)acrylic acid derivatives gels and their manufacture CHEMISCHE FABRIK STOCKHAUSEN GMBH (DE) 1983-01-04 US disclosed
US-4217209-A Process for removing heavy metal sulphides from aqueous systems BAYER AKTIENGESELLSCHAFT (DE) 1980-08-12 US disclosed